Crossmark

Intravitreal ranibizumab reduced ocular blood flow and aqueous cytokine levels and improved retinal morphology in patients with diabetic macular edema

Crossref DOI link: https://doi.org/10.1038/s41598-020-78792-3

Published Online: 2020-12-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mizui, Toru

Noma, Hidetaka

Yasuda, Kanako

Kanemaki, Tomoe

Goto, Hiroshi

Shimura, Masahiko
License Information

Text and Data Mining valid from 2020-12-10

Version of Record valid from 2020-12-10
More Information

Article History

Received: 20 June 2020

Accepted: 23 November 2020

First Online: 10 December 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below